Showing 1 - 4 results of 4 for search 'Amy E. Bock', query time: 0.02s Refine Results
  1. 1
    Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis

    Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis by Jonathan Kay, Muhammad Rehman, Noriko Iikuni, Daniel F Alvarez, Amy E Bock, Wuyan Zhang

    Published 2022-11-01
    Get full text
    Article
  2. 2
    Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26–52, including a treatment switch from reference ADL to PF-06410293

    Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26–52, including a... by Rieke Alten, Carol Cronenberger, Daniel F Alvarez, Amy E Bock, Ivana Vranic, Wuyan Zhang

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®) or continuing biosimilar therapy: week 52–92 data from a randomized, double-blind, phase 3 trial

    Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®)... by Roy M. Fleischmann, Daniel F. Alvarez, Amy E. Bock, Carol Cronenberger, Ivana Vranic, Wuyan Zhang, Rieke Alten

    Published 2021-09-01
    Get full text
    Article
  4. 4
    A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis

    A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis by Roy M. Fleischmann, Rieke Alten, Margarita Pileckyte, Kasia Lobello, Steven Y. Hua, Carol Cronenberger, Daniel Alvarez, Amy E. Bock, K. Lea Sewell

    Published 2018-08-01
    Get full text
    Article

Search Tools: